By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN
It has been more than a year since we’ve introduced the Innovator’s Pitch Challenge (IPC), Life Science Nation’s latest effort to boost exposure for early-stage companies attending the Redefining Early Stage Investment (RESI) conference virtually. Since its inception, the IPC has become one of the most anticipated components of the RESI program. To date, hundreds of early-stage life science and healthcare startups and hundreds of investor and industry expert judges have participated. We are excited to continue growing this dynamic platform of companies and investors, strategic partners, industry experts, and more to facilitate new conversations.
Hear from some of these previous participants about their experience and how the IPC helped them along their fundraising journey:
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
We are actively accepting applications for the Digital RESI JPM Innovator’s Pitch Challenge, where we will showcase innovative technologies across therapeutics, medical devices, diagnostics/tools, and digital health.
Applications are due Friday, December 17 – it’s not too late to apply!
Next Phase Newsletter 
Leave a Reply